Lead Product(s) : TAS-118
Therapeutic Area : Oncology
Study Phase : Phase III
Sponsor : YAKULT HONSHA CO LTD
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : TAS-118 is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Stomach Neoplasms.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
December 23, 2014
Lead Product(s) : TAS-118
Therapeutic Area : Oncology
Highest Development Status : Phase III
Sponsor : YAKULT HONSHA CO LTD
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
